Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Thromb Res. 2012 May;129 Suppl 2(0 2):S57-61. doi: 10.1016/j.thromres.2012.02.035. Epub 2012 Mar 8.
A validated method for assessing hemostasis in vivo is critical for testing the hemostatic efficacy of therapeutic agents in preclinical animal models and in patients with inherited bleeding disorders, such as von Willebrand disease (VWD) and hemophilia A, or with acquired bleeding disorders such as those resulting from medications or disease processes. In this review, we discuss current methods for assessing hemostasis in vivo and the associated challenges. We also present ARFI-Monitored Hemostatic Challenge; a new, potentially alternate method for in vivo hemostasis monitoring that is in development by our group.
评估体内止血的验证方法对于在临床前动物模型和患有遗传性出血性疾病(如血管性血友病(VWD)和血友病 A)或获得性出血性疾病(如药物或疾病过程引起的出血性疾病)的患者中测试治疗剂的止血效果至关重要。在这篇综述中,我们讨论了目前用于评估体内止血的方法和相关挑战。我们还介绍了 ARFI 监测止血挑战;这是我们小组正在开发的一种新的、潜在的替代体内止血监测方法。